- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | VASO Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| Mo | Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024 | 124 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services,... ► Artikel lesen | |
| 13.01. | Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors | 115 | GlobeNewswire (Europe) | PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments... ► Artikel lesen | |
| 03.01. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| VASO Aktie jetzt für 0€ handeln | |||||
| 20.12.24 | SRV YHTIOT OYJ: SRV will implement right-of-occupancy housing units for Vaso in Kuloistenniitty, Raisio - the units will have an energy class A rating | 4 | Cision News | ||
| 16.12.24 | Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 | 115 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX:... ► Artikel lesen | |
| 22.11.24 | Vaso Corp CEO Ma Jun erwirbt Stammaktien im Wert von 26.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 14.11.24 | Vasomedical reports Q3 results | 1 | Seeking Alpha | ||
| 14.11.24 | Vaso Corporation Announces Financial Results for Third Quarter 2024 | 136 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 19.09.24 | Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I | 143 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I ("Achari") to terminate... ► Artikel lesen | |
| 14.08.24 | Vaso Corporation Announces Financial Results for Second Quarter 2024 | 124 | GlobeNewswire (Europe) | High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating... ► Artikel lesen | |
| 15.05.24 | Vaso Corporation Announces Financial Results for First Quarter 2024 | 155 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. "Total revenue for the first... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 21,290 | +0,12 % | Aktien Frankfurt: Unsicherheit vor Trump-Zollbekanntgabe belastet | FRANKFURT (dpa-AFX) - Vor der erwarteten Zollankündigung von US-Präsident Donald Trump haben sich die Anleger am deutschen Aktienmarkt zur Wochenmitte zurückgezogen. Die kräftige Erholung am Vortag... ► Artikel lesen | |
| ASTRAZENECA | 132,50 | -2,07 % | Aktien Europa Schluss: Schwache Märkte blicken mit Sorgen auf US-Zölle | PARIS/LONDON/ZÜRICH (dpa-AFX) - Die am Abend anstehende Ankündigung von Importzöllen der Vereinigten Staaten hat Europas Börsen am Mittwoch belastet. Kurz vor der mit großen Unwägbarkeiten behafteten... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 4,537 | +0,55 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 25,510 | +1,47 % | Ionis Aktie: Alles auf den Punkt gebracht | Ionis Pharmaceuticals verstärkt Zusammenarbeit mit Sobi und fördert weltweite Olezarsen-Vermarktung außerhalb der USA. Ionis Pharmaceuticals stärkt seine Position im Biotechnologiesektor durch strategische... ► Artikel lesen | |
| CSPC PHARMA | 0,624 | -0,22 % | M Stanley Cuts CSPC PHARMA TP to $6.7, Rating Overweight | ||
| ACADIA PHARMACEUTICALS | 14,610 | -0,07 % | Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 0,998 | -0,40 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update | - Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 293,50 | -1,08 % | AKTIONÄR-Hot-Stock Madrigal: Erneute Übernahmegerüchte - Aktie mit Kurssprung | Am späten Freitagabend hat die Aktie des Biotech-Unternehmens Madrigal einen starken Kursanstieg verzeichnet. Erneut halten sich Gerüchte um die Gesellschaft, die mit Rezdiffra (Resmetirom) die erste... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 21,650 | -1,01 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | Full Year 2024 Total Revenues of $491.7 Million, Marking Another Year of Record Growth Full Year 2024 Total Revenues Grew 23.5% YoY, Driven by Strong Commercial Performance Q4 2024 Net... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,077 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| OPUS GENETICS | 0,835 | -5,86 % | Opus Genetics, Inc.: Opus Genetics Announces Financial Results for Full Year 2024 | Provides update on the Company's transformation and promising portfolio of innovative gene therapy treatments for inherited retinal diseases Strong cash position with $21.5 million financing to supplement... ► Artikel lesen | |
| CHUGAI PHARMACEUTICAL | 40,570 | +1,35 % | Dividendenbekanntmachungen (27.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 3 JPY 0,0182 EUR AGC INC JP3112000009 105 JPY 0,6373 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line | Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,009 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 10.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.02.2025ISIN NameES0105015012 LAR... ► Artikel lesen | |
| SAVARA | 2,600 | +0,78 % | Savara: Loan & Security Agreement Signed For Up To $200 Million With Hercules Capital |
Das Unternehmen VASO CORPORATION kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.
